Drug
Enoblituzumab Schedule 1
Enoblituzumab Schedule 1: highest development phase Phase 1, developed by MacroGenics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- MacroGenics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Enoblituzumab Schedule 1 NCT02475213 | Phase 1 | Melanoma |
Latest
No recent events.
Follow Enoblituzumab Schedule 1 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.